Share this page

TAK

$18.19-1.73%

as of close, Sep 30, 2026

☾ AH $18.19 -1.73%

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)Stock · Health Care

PeersMRNALLYUNHJNJMRKTMO

How Takeda Pharmaceutical ADR makes money

Period

FY2026

How does Takeda Pharmaceutical ADR make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) · FY2026 · year ended 2026-03-31

Revenue$29.8BNet loss$941M · 3%Cost of revenue$10.4B · 35%Gross profit$19.4B · 65%Operating expenses$19.4B · 65%R&D$4.5B · 15%Other opex$14.9B · 50%Other expense$941M · 3%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.